Mice Model Market is expected to generate a revenue of USD 2464.65 Million by 2027, Globally, at 7.65% CAGR: Verified Market Research®
13 sept. 2022 11h15 HE
|
Verified Market Research
Jersey City, New Jersey, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Mice Model Market” By Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice,...
Certara Appoints Eran Broshy as New Independent Board Member
13 juil. 2022 08h00 HE
|
Certara
PRINCETON, N.J., July 13, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Eran Broshy to its Board of Directors, effective...
Certara to Report First Quarter 2022 Financial Results on May 5th, 2022
20 avr. 2022 08h00 HE
|
Certara
PRINCETON, N.J., April 20, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of...
Biopharmaceutical Contract Manufacturing Market to reach US$ 18.7 Billion by 2029 - Comprehensive Research Report by FMI
07 avr. 2022 20h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
Top Companies Covered in Biopharmaceutical Contract Manufacturing Market are Catalent Inc., Lonza Group Ag, Patheon N.V. (Thermo Fisher Scientific Inc.), Abzena Plc., Sandoz International GmbH...
Laboratory Filtration Market is Expected to Reach $6.8 Billion by 2030, Says Allied Market Research
14 déc. 2021 04h03 HE
|
Allied Market Research
Portland, OR, Dec. 14, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global laboratory filtration market generated $3.06 billion in 2020, and is projected...
Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award
25 oct. 2021 16h30 HE
|
Certara
PRINCETON, N.J., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that its Simcyp COVID-19 Vaccine Model has won an R&D 100...
Certara Appoints Drayton T. Virkler as Chief Commercial Officer
05 oct. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Drayton T. Virkler to the newly created position...
Certara Launches New Synchrogenix™ Writer Software to Accelerate the Regulatory Submission Process
30 sept. 2021 16h30 HE
|
Certara
PRINCETON, N.J., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced the launch of Synchrogenix™ Writer, a new regulatory SaaS product that expedites the...
Certara Announces Proposed Public Offering of Common Stock
03 sept. 2021 06h10 HE
|
Certara
PRINCETON, N.J., Sept. 03, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering of 20,000,000 shares of...
Certara Appoints Nancy Killefer and Cynthia Collins as New Independent Board Members
15 juil. 2021 16h30 HE
|
Certara
PRINCETON, N.J., July 15, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced the appointments of Nancy Killefer and Cynthia Collins to its board of directors,...